Cardiac glycosides are potent inhibitors of interferon-β gene expression

[1]  L. Rönnblom,et al.  Cytokines as therapeutic targets in SLE , 2010, Nature Reviews Rheumatology.

[2]  Dimitris Thanos,et al.  The transcriptional code of human IFN-beta gene expression. , 2010, Biochimica et biophysica acta.

[3]  J. Lingrel.  The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase. , 2010, Annual review of physiology.

[4]  Zhijian J. Chen,et al.  SnapShot: Pathways of Antiviral Innate Immunity , 2010, Cell.

[5]  A. García-Sastre,et al.  Phosphorylation-Mediated Negative Regulation of RIG-I Antiviral Activity , 2010, Journal of Virology.

[6]  A. Rosen,et al.  Type I interferons: crucial participants in disease amplification in autoimmunity , 2010, Nature Reviews Rheumatology.

[7]  F. Barré-Sinoussi,et al.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. , 2009, The Journal of clinical investigation.

[8]  Ying Zhang,et al.  Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancer , 2009, Cancer.

[9]  Zhijian J. Chen,et al.  RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway , 2009, Cell.

[10]  T. Fujita.  A nonself RNA pattern: tri-p to panhandle. , 2009, Immunity.

[11]  V. Hornung,et al.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate , 2009, Nature Immunology.

[12]  J. Wrana,et al.  Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. , 2009, Cancer research.

[13]  S. Schreiber,et al.  A small molecule that directs differentiation of human ESCs into the pancreatic lineage. , 2009, Nature chemical biology.

[14]  Taekjip Ha,et al.  Cytosolic Viral Sensor RIG-I Is a 5'-Triphosphate–Dependent Translocase on Double-Stranded RNA , 2009, Science.

[15]  Cun-Yu Wang,et al.  MAVS Self-Association Mediates Antiviral Innate Immune Signaling , 2009, Journal of Virology.

[16]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[17]  Eleftherios P. Diamandis,et al.  Novel therapeutic applications of cardiac glycosides , 2008, Nature Reviews Drug Discovery.

[18]  Y. Li,et al.  The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. , 2008, Immunity.

[19]  Judith N. Mandl,et al.  Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections , 2008, Nature Medicine.

[20]  A. Bowie,et al.  Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation , 2008, The EMBO journal.

[21]  D. Swinney,et al.  Essential Role of the N-terminal Domain in the Regulation of RIG-I ATPase Activity* , 2008, Journal of Biological Chemistry.

[22]  F. Inagaki,et al.  Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. , 2008, Molecular cell.

[23]  K. Conzelmann,et al.  The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. , 2008, Molecular cell.

[24]  G. Cheng,et al.  Modulation of the Interferon Antiviral Response by the TBK1/IKKi Adaptor Protein TANK* , 2007, Journal of Biological Chemistry.

[25]  Osamu Takeuchi,et al.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity , 2007, Nature.

[26]  S. Akira,et al.  Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2 , 2007, Proceedings of the National Academy of Sciences.

[27]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[28]  E. Pietras,et al.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif , 2006, The EMBO journal.

[29]  Christine A. Biron,et al.  Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.

[30]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[31]  K. Honda,et al.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. , 2006, Immunity.

[32]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[33]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[34]  J. Hartley,et al.  Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Simon,et al.  Phenamil: An irreversible inhibitor of sodium channels in the toad urinary bladder , 2005, The Journal of Membrane Biology.

[36]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[37]  P. Rorsman,et al.  Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic β-cells , 1986, Pflügers Archiv.

[38]  Zijian Xie,et al.  Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function. , 2003, Molecular interventions.

[39]  T. Maniatis,et al.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. , 2003, Nature immunology.

[40]  D. Tough,et al.  Links between innate and adaptive immunity via type I interferon. , 2002, Current opinion in immunology.

[41]  Martha S. Cyert,et al.  Regulation of Nuclear Localization during Signaling* , 2001, The Journal of Biological Chemistry.

[42]  G. Sen,et al.  Viruses and interferons. , 2001, Annual review of microbiology.

[43]  J. V. Falvo,et al.  Structure and function of the interferon-beta enhanceosome. , 1998, Cold Spring Harbor symposia on quantitative biology.

[44]  I. Izquierdo.  Nimodipine and the recovery of memory. , 1990, Trends in pharmacological sciences.

[45]  T. Maniatis,et al.  Postinduction turnoff of beta-interferon gene expression , 1990, Molecular and cellular biology.

[46]  M. Kawamura,et al.  Site-directed mutagenesis of Asp-376, the catalytic phosphorylation site, and Lys-507, the putative ATP-binding site, of the alpha-subunit of Torpedo californica Na+/K(+)-ATPase. , 1990, Biochimica et biophysica acta.

[47]  G. Langer.  Ionic basis of myocardial contractility. , 1977, Annual review of medicine.